Clinical Trial Update: The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes [NA]

View source ↗

Summary

A clinical trial update examining whether administering a GnRH agonist during the luteal phase affects outcomes of ART cycles in infertility patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Infertility | NA | Status: UNKNOWN